Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies

Clinical trial NCT02182245 · COMPLETED

Trial details

NCT number: NCT02182245
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Genital Neoplasms, Female

Start date: 2005-10-01
Primary completion: 2007-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.